A silybin-phospholipids complex counteracts rat fatty liver degeneration and mitochondrial oxidative changes

World Journal of Gastroenterology

Volumn 19, Issue 20, 2013, Pages 3007-3017

  Grattagliano, Ignazio ^a   Diogo, Catia V ^b   Mastrodonato, Maria ^a   de Bari, Ornella ^c   Persichella, Michele ^a   Wang, David Q H ^c   Liquori, Adriana ^a   Ferri, Domenico ^a   Carratù, Maria Rosaria ^a   Oliveira, Paulo J ^b   Portincasa, Piero ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fatty liver; Glutathione; Lipid peroxidation; Nitrosothiols; Nitrotyrosine; Thioredoxin

Indexed keywords

3 NITROTYROSINE; ALANINE AMINOTRANSFERASE; ALPHA TOCOPHEROL; GLUTATHIONE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; MITOCHONDRIAL PROTEIN; PHOSPHOLIPID; S NITROSOTHIOL; SILIBININ; THIOREDOXIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY LIVER; HISTOLOGY; LIPID STORAGE; LIVER FATTY DEGENERATION; MALE; NONHUMAN; RAT; RESPIRATORY CHAIN; STEATOSIS; WESTERN BLOTTING;

EID: 84878226480     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i20.3007     Document Type: Article

References (54)

1. Humphreys D. Careers extraordinary: "what's on the programme today, sister"? Nurs Times 1972; 68: 308-310 [PMID: 5015760]
2. Portincasa P, Grattagliano I, Palmieri VO, Palasciano G. Nonalcoholic steatohepatitis: recent advances from experimental models to clinical management. Clin Biochem 2005; 38: 203-217 [PMID: 15708540 DOI: 10.1016/j.clinbiochem.200 4.10.014]
3. Grattagliano I, Caraceni P, Calamita G, Ferri D, Gargano I, Palasciano G, Portincasa P. Severe liver steatosis correlates with nitrosative and oxidative stress in rats. Eur J Clin Invest 2008; 38: 523-530 [PMID: 18578693 DOI: 10.1111/ j.1365-2362.2008.01963.x]
4. Palasciano G, Moschetta A, Palmieri VO, Grattagliano I, Iacobellis G, Portincasa P. Non-alcoholic fatty liver disease in the metabolic syndrome. Curr Pharm Des 2007; 13: 2193-2198 [PMID: 17627552]
5. Yang S, Zhu H, Li Y, Lin H, Gabrielson K, Trush MA, Diehl AM. Mitochondrial adaptations to obesity-related oxidant stress. Arch Biochem Biophys 2000; 378: 259-268 [PMID: 10860543 DOI: 10.1006/abbi.2000.1829]
6. Merriman RB, Aouizerat BE, Bass NM. Genetic influences in nonalcoholic fatty liver disease. J Clin Gastroenterol 2006; 40. Suppl 1: S30-S33 [PMID: 16540764 DOI: 10.1097/01. mcg.0000168643.16074.19]
7. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Clore JN. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001; 120: 1183-1192 [PMID: 11266382]
8. Shteyer E, Liao Y, Muglia LJ, Hruz PW, Rudnick DA. Disruption of hepatic adipogenesis is associated with impaired liver regeneration in mice. Hepatology 2004; 40: 1322-1332 [PMID: 15565660 DOI: 10.1002/hep.20462]
9. Yamaguchi K, Yang L, McCall S, Huang J, Yu XX, Pandey SK, Bhanot S, Monia BP, Li YX, Diehl AM. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology 2007; 45: 1366-1374 [PMID: 17476695 DOI: 10.1002/hep.21655]
10. Trevisani F, Colantoni A, Caraceni P, Van Thiel DH. The use of donor fatty liver for liver transplantation: a challenge or a quagmire? J Hepatol 1996; 24: 114-121 [PMID: 8834034]
11. Hu JJ, Roush GC, Berwick M, Dubin N, Mahabir S, Chandiramani M, Boorstein R. Effects of dietary supplementation of alpha-tocopherol on plasma glutathione and DNA repair activities. Cancer Epidemiol Biomarkers Prev 1996; 5: 263-270 [PMID: 8722217]
12. Trappoliere M, Caligiuri A, Schmid M, Bertolani C, Failli P, Vizzutti F, Novo E, di Manzano C, Marra F, Loguercio C, Pinzani M. Silybin, a component of sylimarin, exerts antiinflammatory and anti-fibrogenic effects on human hepatic stellate cells. J Hepatol 2009; 50: 1102-1111 [PMID: 19398228 DOI: 10.1016/j.jhep.2009.02.023]
13. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 1969; 27: 502-522 [PMID: 4388022]
14. Grattagliano I, Russmann S, Palmieri VO, Portincasa P, Palasciano G, Lauterburg BH. Glutathione peroxidase, thioredoxin, and membrane protein changes in erythrocytes predict ribavirin-induced anemia. Clin Pharmacol Ther 2005; 78: 422-432 [PMID: 16198661 DOI: 10.1016/j.clpt.2005.07.002]
15. Slater TF, Sawyer BC. The stimulatory effects of carbon tetrachloride on peroxidative reactions in rat liver fractions in vitro. Inhibitory effects of free-radical scavengers and other agents. Biochem J 1971; 123: 823-828 [PMID: 5001363]
16. Flohé L, Günzler WA. Assays of glutathione peroxidase. Methods Enzymol 1984; 105: 114-121 [PMID: 6727659]
17. Cook JA, Kim SY, Teague D, Krishna MC, Pacelli R, Mitchell JB, Vodovotz Y, Nims RW, Christodoulou D, Miles AM, Grisham MB, Wink DA. Convenient colorimetric and fluorometric assays for S-nitrosothiols. Anal Biochem 1996; 238: 150-158 [PMID: 8660604]
18. Begriche K, Igoudjil A, Pessayre D, Fromenty B. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 2006; 6: 1-28 [PMID: 16406828 DOI: 10.1016/j.mito.2005.10.004]
19. Bray GA, Nielsen SJ, Popkin BM. Consumption of high-fruc-tose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 2004; 79: 537-543 [PMID: 15051594]
20. Jew S, AbuMweis SS, Jones PJ. Evolution of the human diet: linking our ancestral diet to modern functional foods as a means of chronic disease prevention. J Med Food 2009; 12: 925-934 [PMID: 19857053 DOI: 10.1089/jmf.2008.0268]
21. Nicolson GL. Metabolic syndrome and mitochondrial function: molecular replacement and antioxidant supplements to prevent membrane peroxidation and restore mitochondrial function. J Cell Biochem 2007; 100: 1352-1369 [PMID: 17243117 DOI: 10.1002/jcb.21247]
22. Federspil G, Nisoli E, Vettor R. A critical reflection on the definition of metabolic syndrome. Pharmacol Res 2006; 53: 449-456 [PMID: 16632375 DOI: 10.1016/j.phrs.2006.03.008]
23. Yu S, Matsusue K, Kashireddy P, Cao WQ, Yeldandi V, Yeldandi AV, Rao MS, Gonzalez FJ, Reddy JK. Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression. J Biol Chem 2003; 278: 498-505 [PMID: 12401792 DOI: 10.1074/jbc.M210062200]
24. Le TH, Caldwell SH, Redick JA, Sheppard BL, Davis CA, Arseneau KO, Iezzoni JC, Hespenheide EE, Al-Osaimi A, Peterson TC. The zonal distribution of megamitochondria with crystalline inclusions in nonalcoholic steatohepatitis. Hepatology 2004; 39: 1423-1429 [PMID: 15122772 DOI: 10.1002/ hep.20202]
25. Altunkaynak BZ, Ozbek E. Overweight and structural alterations of the liver in female rats fed a high-fat diet: a stereological and histological study. Turk J Gastroenterol 2009; 20: 93-103 [PMID: 19530041]
26. Kowaltowski AJ, de Souza-Pinto NC, Castilho RF, Vercesi AE. Mitochondria and reactive oxygen species. Free Radic Biol Med 2009; 47: 333-343 [PMID: 19427899 DOI: 10.1016/ j.freeradbiomed.2009.05.004]
27. Tahara EB, Navarete FD, Kowaltowski AJ. Tissue-, substrate-, and site-specific characteristics of mitochondrial reactive oxygen species generation. Free Radic Biol Med 2009; 46: 1283-1297 [PMID: 19245829 DOI: 10.1016/j.freeradbiomed.20 09.02.008]
28. Nishikawa T, Kukidome D, Sonoda K, Fujisawa K, Matsuhisa T, Motoshima H, Matsumura T, Araki E. Impact of mitochondrial ROS production in the pathogenesis of insulin resistance. Diabetes Res Clin Pract 2007; 77 Suppl 1: S161-S164 [PMID: 17481767 DOI: 10.1016/j.diabres.2007.01.071]
29. Facundo HT, Fornazari M, Kowaltowski AJ. Tissue protection mediated by mitochondrial K+ channels. Biochim Biophys Acta 2006; 1762: 202-212 [PMID: 16026967 DOI: 10.1016/ j.bbadis.2005.06.003]
30. Ferranti R, da Silva MM, Kowaltowski AJ. Mitochondrial ATP-sensitive K+ channel opening decreases reactive oxygen species generation. FEBS Lett 2003; 536: 51-55 [PMID: 12586337 DOI: 10.1016/S0014-5793(03)00007-3]
31. Fornazari M, de Paula JG, Castilho RF, Kowaltowski AJ. Redox properties of the adenoside triphosphate-sensitive K+ channel in brain mitochondria. J Neurosci Res 2008; 86: 1548-1556 [PMID: 18189325 DOI: 10.1002/jnr.21614]
32. Yang S, Lin H, Diehl AM. Fatty liver vulnerability to endotoxin-induced damage despite NF-kappaB induction and inhibited caspase 3 activation. Am J Physiol Gastrointest Liver Physiol 2001; 281: G382-G392 [PMID: 11447019]
33. García-Ruiz I, Rodríguez-Juan C, Díaz-Sanjuan T, del Hoyo P, Colina F, Muñoz-Yagüe T, Solís-Herruzo JA. Uric acid and anti-TNF antibody improve mitochondrial dysfunction in ob/ob mice. Hepatology 2006; 44: 581-591 [PMID: 16941682 DOI: 10.1002/hep.21313]
34. Ottesen LH, Harry D, Frost M, Davies S, Khan K, Halliwell B, Moore K. Increased formation of S-nitrothiols and nitrotyrosine in cirrhotic rats during endotoxemia. Free Radic Biol Med 2001; 31: 790-798 [PMID: 11557317 DOI: 10.1016/ S0891-5849(01)00647-5]
35. Nakamura H, Nakamura K, Yodoi J. Redox regulation of cellular activation. Annu Rev Immunol 1997; 15: 351-369 [PMID: 9143692 DOI: 10.1146/annurev.immunol.15.1.351]
36. Nikitovic D, Holmgren A. S-nitrosoglutathione is cleaved by the thioredoxin system with liberation of glutathione and redox regulating nitric oxide. J Biol Chem 1996; 271: 19180-19185 [PMID: 8702596]
37. Stoyanovsky DA, Tyurina YY, Tyurin VA, Anand D, Mandavia DN, Gius D, Ivanova J, Pitt B, Billiar TR, Kagan VE. Thioredoxin and lipoic acid catalyze the denitrosation of low molecular weight and protein S-nitrosothiols. J Am Chem Soc 2005; 127: 15815-15823 [PMID: 16277524 DOI: 10.1021/ ja0529135]
38. Arnelle DR, Stamler JS. NO+, NO, and NO-donation by S-nitrosothiols: implications for regulation of physiological functions by S-nitrosylation and acceleration of disulfide formation. Arch Biochem Biophys 1995; 318: 279-285 [PMID: 7733655 DOI: 10.1006/abbi.1995.1231]
39. Grattagliano I, Portincasa P, Palmieri VO, Palasciano G. Mutual changes of thioredoxin and nitrosothiols during biliary cirrhosis: results from humans and cholestatic rats. Hepatology 2007; 45: 331-339 [PMID: 17256724]
40. Klatt P, Lamas S. Regulation of protein function by S-glutathiolation in response to oxidative and nitrosative stress. Eur J Biochem 2000; 267: 4928-4944 [PMID: 10931175 DOI: 10.1046/j.1432-1327.2000.01601.x]
41. Dunn W, Xu R, Wingard DL, Rogers C, Angulo P, Younossi ZM, Schwimmer JB. Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. Am J Gastroenterol 2008; 103: 2263-2271 [PMID: 18684196 DOI: 10.1111/j.1572-0241.2008.02034.x]
42. Grattagliano I, Palmieri VO, Portincasa P, Moschetta A, Palasciano G. Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis. J Nutr Biochem 2008; 19: 491-504 [PMID: 17855068 DOI: 10.1016/j.jnutbio.2007.06.011]
43. Linder S. Cytokeratin markers come of age. Tumour Biol 2007; 28: 189-195 [PMID: 17717426]
44. Wieckowska A, Zein NN, Yerian LM, Lopez AR, Mc-Cullough AJ, Feldstein AE. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. Hepatology 2006; 44: 27-33 [PMID: 16799979 DOI: 10.1002/hep.21223]
45. Yilmaz Y, Dolar E, Ulukaya E, Akgoz S, Keskin M, Kiyici M, Aker S, Yilmaztepe A, Gurel S, Gulten M, Nak SG. Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis. World J Gastroenterol 2007; 13: 837-844 [PMID: 17352011 DOI: wjgnet. com/1007-9327/13/837.asp]
46. Caraceni P, Bianchi C, Domenicali M, Maria Pertosa A, Maiolini E, Parenti Castelli G, Nardo B, Trevisani F, Lenaz G, Bernardi M. Impairment of mitochondrial oxidative phosphorylation in rat fatty liver exposed to preservationreperfusion injury. J Hepatol 2004; 41: 82-88 [PMID: 15246212 DOI: 10.1016/j.jhep.2004.03.022]
47. Cardoso AR, Cabral-Costa JV, Kowaltowski AJ. Effects of a high fat diet on liver mitochondria: increased ATP-sensitive K+ channel activity and reactive oxygen species generation. J Bioenerg Biomembr 2010; 42: 245-253 [PMID: 20373005 DOI: 10.1007/s10863-010-9284-9]
48. Di Sario A, Bendia E, Taffetani S, Omenetti A, Candelaresi C, Marzioni M, De Minicis S, Benedetti A. Hepatoprotective and antifibrotic effect of a new silybin-phosphatidylcholine-Vitamin E complex in rats. Dig Liver Dis 2005; 37: 869-876 [PMID: 16169303 DOI: 10.1016/j.dld.2005.05.011]
49. Wellington K, Jarvis B. Silymarin: a review of its clinical properties in the management of hepatic disorders. BioDrugs 2001; 15: 465-489 [PMID: 11520257]
50. Pietrangelo A, Montosi G, Garuti C, Contri M, Giovannini F, Ceccarelli D, Masini A. Iron-induced oxidant stress in nonparenchymal liver cells: mitochondrial derangement and fibrosis in acutely iron-dosed gerbils and its prevention by silybin. J Bioenerg Biomembr 2002; 34: 67-79 [PMID: 11860182]
51. Morazzoni P, Montalbetti A, Malandrino S, Pifferi G. Comparative pharmacokinetics of silipide and silymarin in rats. Eur J Drug Metab Pharmacokinet 1993; 18: 289-297 [PMID: 8149949]
52. Pietrangelo A, Borella F, Casalgrandi G, Montosi G, Ceccarelli D, Gallesi D, Giovannini F, Gasparetto A, Masini A. Antioxidant activity of silybin in vivo during long-term iron overload in rats. Gastroenterology 1995; 109: 1941-1949 [PMID: 7498660]
53. Moon KH, Hood BL, Mukhopadhyay P, Rajesh M, Abdelmegeed MA, Kwon YI, Conrads TP, Veenstra TD, Song BJ, Pacher P. Oxidative inactivation of key mitochondrial proteins leads to dysfunction and injury in hepatic ischemia reperfusion. Gastroenterology 2008; 135: 1344-1357 [PMID: 18778711 DOI: 10.1053/j.gastro.2008.06.048]
54. Serviddio G, Bellanti F, Giudetti AM, Gnoni GV, Petrella A, Tamborra R, Romano AD, Rollo T, Vendemiale G, Altomare E. A silybin-phospholipid complex prevents mitochondrial dysfunction in a rodent model of nonalcoholic steatohepatitis. J Pharmacol Exp Ther 2010; 332: 922-932 [PMID: 20008062 DOI: 10.1124/jpet.109.161612]